The New York Police Department monitored Muslim college students far more broadly than previously known, at schools far beyond the city limits, including the elite Ivy League colleges of Yale and the University of Pennsylvania, The Associated Press has learned
Shock and Awe: Use our magic to get the natives to submit
The #USA #military made #racist assumption that Shock and Awe in #Iraq would lead to total surrender.
Just like some believe that the First Nations of Central America allowed the Spanish to conquer them because they thought a white god would come from the east, or that the Spaniards’ horses and guns created a mystical fear which prevented resistance, the United States believed it could use overwhelming military force (pdf) to end all resistance quickly and turn Iraq into an oil-revenue generating colony.
Since before Sun Tzu and the earliest chroniclers of war recorded their observations, strategists and generals have been tantalized and confounded by the illusive goal of destroying the adversary’s will to resist before, during, and after battle. Today, we believe that an unusual opportunity exists to determine whether or not this long-sought strategic goal of affecting the will, understanding, and perception of an adversary can be brought closer to fruition.
“What the EU is trying to do with this trade agreement is effectively slowly poison the production of affordable generic medicines in India, which has helped keep so many people alive. This trade agreement could target us as treatment providers, simply for buying generic medicines from India to treat patients in our programs.”—
Piero Gandini Head of Mission for MSF in India
India has been called the “pharmacy of the developing world” because it produces a large number of high-quality, affordable generic medicines. MSF and other treatment providers also rely on Indian generic medicines to treat other diseases and conditions.
However, a free trade agreement (FTA) currently under negotiation between the European Union (EU) and India could greatly restrict the ability of Indian generic manufacturers to continue producing high-quality, affordable medicines that millions of people with HIV/AIDS and other diseases and conditions rely on to stay alive.